Associate Professor Philip Beale

Associate Professor
Medicine, Concord Clinical School

Telephone +61 2 9515 6183

Map

Selected grants

2014

  • PARAGON: Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological neoplasms; Friedlander M, Sjoquist K, Beale P; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2013

  • ICON8: An international multi-stage randomised phase III trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy for women with newly diagnosed epithelial ovarian cancer; Friedlander M, Quinn M, Mileshkin L, Ledermann J, Clamp A, Dean A, Beale P, Sjoquist K, Martyn J; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2010

  • Next-generation high-speed flow cytometric cell sorter; Fazekas de St Groth B, King N, Simpson S, Britton W, Campbell I, Vadas M, Grau G, Weninger W, Christopherson R, Gamble J, Rasko J, McCaughan G, Xia P, Beale P, Holst J, Haass N, Combes V, Saunders B, Byrne S, West N, Gorrell M, Bertolino P, Bowen D, Warner F, Seth D, Grimshaw M, Jolly C, Martiniello-Wilks R, Mrass P, Lyons G, Sword G; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2007

  • ICON 7 A randomised, two-arm, multi-centre gynaecologic cancer intergroup trial of adding bevacizumab to standard chemotherapy (carboplatin and paclitaxel) in patients with ovarian cancer; Beale P; Medical Research Council (UK)/Research Support.
  • Use of Proteomic Analyses to improve the management of colorectal cancer - the SCRIPT for CRC Projec; Chan C, Kohonen-Corish M, Robertson G, Clarke S, Baker M, Beale P, Christopherson R, Bokey E, Horvath L, Lin B, Hong A, Solomon M, Chapuis P, McKay M, Mark M; Cancer Institute New South Wales/Translational Program Grant.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Huq, F., Beale, P., Yu, J. (2009). Studies on New Platinum Compounds. In Andrea Bonetti, Roberto Leone,Franco M Muggia, Stephen B Howell (Eds.), Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, (pp. 11-17). US: Humana Press.

Journals

  • Huq, F., Yu, J., Beale, P., Chan, C., Arzuman, L., Nessa, M., Mazumder, M. (2014). Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer. Anticancer Research, 34(1), 541-545.
  • Wu, J., Ludlow, J., De Vries, B., Black, K., Beale, P. (2014). Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success. Australian and New Zealand Journal of Obstetrics and Gynaecology, 54(5), 469-474. [More Information]
  • Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres. Journal of Biomedical Science, 21(1), 1-12. [More Information]
  • Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and Antitumour Activity of a New Trinuclear Platinum Compound [{cis-PtCI(NH3)2u {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] CI4 in Human Ovarian Cancer Cells. Anticancer Research, 34(4), 1923-1929.
  • Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2013). Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumor models. Journal of Ovarian Research, 6(Nov 2013), 1-11. [More Information]
  • Vardy, J., Dhillon, H., Clarke, S., Olesen, I., Leslie, F., Warby, A., Beith, J., Sullivan, A., Hamilton, A., Beale, P., Rittau, A., McLachlan, A. (2013). Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus, 2(1), 1-5. [More Information]
  • Stark, D., Nankivell, M., Pujade-Lauraine, E., Kristensen, G., Elit, L., Stockler, M., Hilpert, F., Cervantes, A., Brown, J., Lanceley, A., et al (2013). Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. Lancet Oncology, 14(3), 236-243. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2013). Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models. Medicinal Chemistry, 9(4), 539-544. [More Information]
  • Lim, S., Wilson, S., Hunter, A., Jane, H., Beale, P. (2013). Takotsubo Cardiomyopathy and 5-Fluorouracil: Getting to the Heart of the Matter. Case Reports in Oncological Medicine, 2013, 206765. [More Information]
  • Kiely, B., Martin, A., Tattersall, M., Nowak, A., Goldstein, D., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Stockler, M., et al (2013). The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates. Journal of Clinical Oncology, 31(28), 3565-3571. [More Information]
  • Kiely, B., McCaughan, G., Christodoulou, S., Beale, P., Grimison, P., Trotman, J., Tattersall, M., Stockler, M. (2013). Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer, 21(2), 369-376. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells. Anticancer Research, 32(1), 53-59. [More Information]
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Lee, M., Rosenthal, D., Larkey, L., Vardy, J. (2012). Effect of Medical Qigong on Cognitive function, Quality of Life and a Biomarker of Inflammation in Cancer Patients: A Randomized Controlled Trial. Supportive Care in Cancer, 20(6), 1235-1242. [More Information]
  • Mazumder, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Epigallocatechin Gallate Acts Synergistically in Combination with Cisplatin and Designed trans-palladiums in Ovarian Cancer Cells. Anticancer Research, 32(11), 4851-4860. [More Information]
  • Dimoska, A., Butow, P., Lynch, J., Hovey, E., Agar, M., Beale, P., Tattersall, M. (2012). Implementing patient question-prompt lists into routine cancer care. Patient Education and Counseling, 86(2), 252-258. [More Information]
  • Chua, W., Horvath, L., Beale, P., Clarke, S. (2012). Reporting clinical trial information: colorectal cancer trials at Sydney Cancer Centre. Internal Medicine Journal, 42(4), 416-421. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Studies on combination of platinum drugs Cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models. Anticancer Research, 32(11), 4843-4850. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Huq, F. (2012). Studies on the activity of two trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models. Anticancer Research, 32(12), 5331-5336. [More Information]
  • Hamad, S., Beale, P., Yu, J., Fisher, K., Huq, F. (2012). Synthesis and Activity of [{Cis-PtC1(NH3)2}2m{Trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]C14 in the human ovarian tumour models. Medicinal Chemistry, 8(3), 384-391. [More Information]
  • Mazumder, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Synthesis and Cytotoxicity of Three trans-Palladium Complexes Containing Planaramine Ligands in Human Ovarian Tumor Models. ChemMedChem: chemistry enabling drug discovery, 7(10), 1840-1846. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2012). Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models. Anticancer Research, 32(1), 135-140. [More Information]
  • Kho, P., Chapuis, P., Beale, P., Bokey, E., Dent, O., Clarke, S. (2012). Use of adjuvant chemotherapy in stage C (III) rectal cancer: Comparison of data from matched patients in a teaching hospital's clinico-pathological database. Asia-Pacific Journal of Clinical Oncology, 8(4), 346-355. [More Information]
  • Anderson, C., Carter, J., Nattress, K., Beale, P., Philp, S., Harrison, J., Juraskova, I. (2011). "The Booklet Helped Me Not to Panic" A Pilot of a Decision Aid for Asymptomatic Women With Ovarian Cancer and With Rising CA-125 Levels. International Journal of Gynecological Cancer, 21(4), 737-743. [More Information]
  • Perren, T., Swart, A., Pfisterer, J., Ledermann, J., Pujade-Lauraine, E., Kristensen, G., Carey, M., Beale, P., Cervantes, A., Kurzeder, C., et al (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26), 2484-2496. [More Information]
  • Friedlander, M., Trimble, E., Tinker, A., Alberts, D., Avall-Lundqvist, E., Brady, M., Harter, P., Pignata, S., Pujade- Lauraine, E., Sehouli, J., Beale, P., et al (2011). Clinical Trials in Recurrent Ovarian Cancer. International Journal Of Gynecological Cancer, 21(4), 771-775. [More Information]
  • Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2011). Modulation of Cisplatin Cytotoxicity due to its Combination with Bortezomib and the Nature of its Administration. Anticancer Research, 31(9), 2757-2762. [More Information]
  • Cox, K., Goel, S., O'Connell, R., Boyer, M., Beale, P., Simes, R., Stockler, M. (2011). Randomized cross-over trial comparing inpatient and outpatient administration of high-dose cisplatin. Internal Medicine Journal, 41(2), 172-178. [More Information]
  • Al-Shuneigat, J., Qing, Y., Beale, P., Fisher, K., Huq, F. (2011). Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3). Medicinal Chemistry, 7(1), 1-8. [More Information]
  • Leighl, N., Shepherd, H., Butow, P., Clarke, S., McJannett, M., Beale, P., Wilcken, N., Moore, M., Chen, E., Goldstein, D., Horvath, L., Tattersall, M., et al (2011). Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering Chemotherapy. Journal of Clinical Oncology, 29(15), 2077-2084. [More Information]
  • Alshehri, A., Beale, P., Yu, J., Huq, F. (2011). Synergism from Combination of Cisplatin and Multicentred Platinums Coded as DH6Cl and TH1 in the Human Ovarian Tumour Models. Medicinal Chemistry, 7(6), 593-598. [More Information]
  • Yunos, N., Beale, P., Yu, J., Huq, F. (2011). Synergism from Sequenced Combinations of Curcumin and Epigallocatechin-3-gallate with Cisplatin in the Killing of Human Ovarian Cancer Cells. Anticancer Research, 31(4), 1131-1140. [More Information]
  • Yunos, N., Beale, P., Yu, J., Huq, F. (2011). Synergism from the Combination of Oxaliplatin with Selected Phytochemicals in Human Ovarian Cancer Cell Lines. Anticancer Research, 31(12), 4283-4289. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2011). Synergism from Vombinations of Cisplatin and Oxaliplatin with Quercetin and Thymoquinone in Human Ovarian Tumour Models. Anticancer Research, 31(11), 3789-3797. [More Information]
  • Blinman, P., Duric, V., Nowak, A., Beale, P., Clarke, S., Briscoe, K., Boyce, A., Goldstein, D., Hudson, M., Stockler, M. (2010). Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile? European Journal of Cancer, 46(10), 1800-1807. [More Information]
  • Lam, F., Jankova, L., Dent, O., Molloy, M., Kwun, S., Clarke, C., Chapuis, P., Robertson, G., Beale, P., Clarke, S., Bokey, E., Chan, C. (2010). Identification of distinctive protein expression patterns in colorectal adenoma. Proteomics - Clinical Applications, 4(1), 60-70. [More Information]
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Kothe, E., Lam, L., Rosenthal, D. (2010). Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Annals of Oncology, 21(3), 608-614. [More Information]
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Tattersall, M., Boyer, M., Beale, P., Vardy, J., Pavlakis, N., Larke, L. (2010). Patient-Doctor Communication: Use of Complementary and Alternative Medicine by Adult Patients with Cancer. Journal of the Society for Integrative Oncology, 8(2), 56-64. [More Information]
  • Yunos, N., Beale, P., Yu, J., Strain, D., Huq, F. (2010). Studies on combinations of platinum with Paclitaxel and colchicine in ovarian cancer cell lines. Anticancer Research, 30(10), 4025-4037. [More Information]
  • Al-Shuneigat, J., Yu, J., Beale, P., Fisher, K., Huq, F. (2010). Studies on Two New mixed Ligand Platinum Compounds with a Trans-Geometry. Medicinal Chemistry, 6(5), 321-328. [More Information]
  • Alshehri, A., Beale, P., Yu, J., Huq, F. (2010). Synergism from combination of Cisplatin and a trans-platinum compound in ovarian cancer cell lines. Anticancer Research, 30(11), 4547-4553. [More Information]
  • Oh, B., Butow, P., Mullan, B., Beale, P., Pavlakis, N., Rosenthal, D., Clarke, S. (2010). The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia-Pacific Journal of Clinical Oncology, 6(4), 342-349. [More Information]
  • Chapuis, P., Bokey, E., Clarke, S., Beale, P., Dent, O. (2009). Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting. ANZ Journal of Surgery, 79(10), 685-692. [More Information]
  • Vardy, J., Dadasovich, R., Beale, P., Boyer, M., Clarke, S. (2009). Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC Cancer, 9(Article number 130), 130-1-130-6. [More Information]
  • Kao, S., Mahon, K., Rutland, J., Pawsey, C., McCaughan, B., Beale, P. (2009). Pleural well-differentiated papillary mesothelioma: a case report. Journal of Thoracic Oncology, 4(7), 920-922. [More Information]
  • Harrison, J., Juraskova, I., Anderson, C., Nattress, K., Beale, P., Lopez, A., Carter, J. (2009). Rising cancer antigen 125 level and the type and timing of treatment for recurrent ovarian cancer: a clinical dilemma, but what would women do? International Journal of Gynecological Cancer, 19(6), 1037-1046. [More Information]
  • Farhad, M., Yu, J., Beale, P., Fisher, K., Huq, F. (2009). Studies on the synthesis and activity of three tripalladium complexes containing planaramine ligands. ChemMedChem: chemistry enabling drug discovery, 4(11), 1841-1849. [More Information]
  • Huq, F., Tayyem, H., Yu, J., Beale, P., Fisher, K. (2009). Synthesis, activity and binding with DNA of [{trans-PtCl(NH3)2}2mu-{trans-Pd(4-hydroxypyridine)2(H2N(CH2)6NH2)2]Cl4 (TH8). Medicinal Chemistry, 5(4), 372-381. [More Information]
  • Diakos, C., Zhang, M., Beale, P., Fenton, R., Hambley, T. (2009). Synthesis, characterisation and in vitro cytotoxicity studies of a series of chiral platinum(II) complexes based on the 2-aminomethylpyrrolidine ligand: X-ray crystal structure of [PtC12(R-dimepyrr)] (R-dimepyrr = N-dimethyl-2(R)-aminomethylpyrrolidine). European Journal of Medicinal Chemistry, 44(7), 2807-2814. [More Information]
  • Chua, W., Moore, M., Beale, P., Clarke, S. (2009). Third-line Treatment Options for Metastatic Colorectal Cancer. Asia Pacific Journal of Oncology and Hematology, 1(1), 27-35.
  • Van Cutsem, E., Verslype, C., Beale, P., Clarke, S., Bugat, R., Rakhit, A., Fettner, S., Brennscheidt, U., Feyereislova, A., Delord, J. (2008). A phase lb dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients. Annals of Oncology, 19(2), 332-339. [More Information]
  • Chua, W., Beale, P., Clarke, S., Leung, M. (2008). Retrospective review of mitomycin C use as third-line chemotherapy in metastatic colorectal cancer. Asia-Pacific Journal of Clinical Oncology, 4(3), 132-136.
  • Tayyem, H., Huq, F., Yu, J., Beale, P., Fisher, K. (2008). Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH(3))(2)}(2)mu-{trans-Pt(3-hydroxypyridine)(2)(H(2)N(CH(2))(6)NH(2))(2)}]Cl(4) in ovarian cancer cell lines. ChemMedChem: chemistry enabling drug discovery, 3(1), 145-151. [More Information]
  • Stockler, M., O'Connell, R., Nowak, A., Goldstein, D., Turner, J., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Dhillon, H., Heritier, S., Carter, C., Hickie, I., Simes, R., et al (2007). Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncology, 8(7), 603-612. [More Information]
  • Yeo, W., Boyer, M., Chung, H., Ong, S., Lim, R., Zee, B., Ma, B., Lam, K., Mo, F., Ng, E., Clarke, S., Beale, P., et al (2007). Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG). Cancer Chemotherapy and Pharmacology, 59(3), 295-300. [More Information]
  • Clarke, S., Goldstein, D., Mitchell, P., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S. (2007). Modification of Leucovorin Dose Within a Simplified FOLFOX Regimen Improves Tolerability Without Compromising Efficacy. Clinical Colorectal Cancer, 6(8), 578-582. [More Information]
  • Harnett, P., Buck, M., Beale, P., Goldrick, A., Allan, S., Fitzharris, B., De Souza, P., Links, M., Kalimi, G., Davies, T., et al (2007). Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study. International Journal Of Gynecological Cancer, 17(2), 359-366. [More Information]
  • Tinker, A., Gebski, V., Fitzharris, B., Buck, M., Stuart-Harris, R., Beale, P., Goldrick, A., Rischin, D. (2007). Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel-ANZGOG 02-01. Gynecologic Oncology, 104(3), 647-653. [More Information]
  • Leighl, N., Shepherd, H., Butow, P., Clarke, S., McJannett, M., Beale, P., Wilcken, N., Moore, M., Chen, E., Tattersall, M., Goldstein, D. (2007). When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer. Journal of Clinical Oncology, 25(18S), 6509.
  • Soo, R., Wang, L., Tham, L., Yong, W., Boyer, M., Lee, H., Lim, H., Millward, M., Liang, S., Beale, P., et al (2006). A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer. Annals of Oncology, 17(7), 1128-1133.
  • Sharma, R., Rivory, L., Beale, P., Ong, S., Horvath, L., Clarke, S. (2006). A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer. British Journal of Cancer, 94(7), 964-968. [More Information]
  • Tobin, P., Beale, P., Noney, L., Liddell, S., Rivory, L., Clarke, S. (2006). A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology, 57(3), 309-316. [More Information]
  • Mitchell, P., Goldstein, D., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Thomson, J., Clarke, S. (2006). Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity. Clinical Colorectal Cancer, 6(2), 146-151. [More Information]
  • Read, J., Choy, S., Beale, P., Clarke, S. (2006). An evaluation of the prevalence of malnutrition in cancer patients attending the outpatient oncology clinic. Asia-Pacific Journal of Clinical Oncology, 2(2), 80-86.
  • Huq, F., Abdullah, A., Beale, P. (2006). Antitumour activity of cis-bis{imidazo(1,2-alpha)pyridineplatinum(II). International Journal of Cancer Research, 2(4), 367-375.
  • Stockler, M., Tattersall, M., Boyer, M., Clarke, S., Beale, P., Simes, R. (2006). Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer. British Journal of Cancer, 94(2), 208-212. [More Information]
  • Read, J., Choy, S., Beale, P., Clarke, S. (2006). Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutrition and Cancer: an international journal, 55(1), 78-85. [More Information]
  • Carter, J., Pather, S., ABDEL-HADI, M., Nattress, K., Dalrymple, C., Beale, P. (2006). Not all ovarian cysts in young woman are benign: A case series and review of the management of complex adnexal masses in young women. Australian and New Zealand Journal of Obstetrics and Gynaecology, 46(4), 350-355. [More Information]
  • Read, J., Beale, P., Volker, D., Smith, N., Childs, A., Clarke, S. (2006). Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Supportive Care in Cancer, 15(3), 301-307. [More Information]
  • Charles (nee Slaviero), K., Rivory, L., Stockler, M., Beale, P., Beith, J., Boyer, M., Clarke, S. (2006). Predicting the toxicity of weekly docetaxel in advanced cancer. Clinical Pharmacokinetics, 45(6), 611-622. [More Information]
  • Michael, M., Goldstein, D., Clarke, S., Milner, A., Beale, P., Friedlander, M., Mitchell, P. (2006). Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count. Clinical Colorectal Cancer, 6(4), 297-304.
  • Huq, F., Farhad, M., Abdullah, A., Beale, P., Zhang, M. (2006). Studies on Oligonuclear Palladium Complexes. Asian Journal of Chemistry, 18(3), 1607-1625.
  • Huq, F., Farhad, M., Abdullah, A., Beale, P., Zhang, M. (2006). Studies on Oligonuclear Palladium Complexes. Asian Journal of Chemistry, 18(3), 1607-1625.
  • Huq, F., Tayyem, H., Beale, P., Yu, J. (2006). Studies on the activity of three palladium(II) compounds of the form: Trans-PdL(2)Cl(2) where L=2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxypyridine. Journal of Inorganic Biochemistry, 101(1), 30-35. [More Information]
  • Huq, F., Abdullah, A., Chowdhury, A., Tayyem, H., Beale, P., Fisher, K. (2006). Studies on the synthesis and characterization, and binding with DNA of two Cis-Planaramineplatinum(II) complexes of the forms: Cis-PtL2Cl2 and Cis-PtL(NH3)Cl2 and where L=3-hydroxypyridine and imidazo(1,2-αlpha) Pyridine. International Journal of Pure and Applied Chemistry, 1(1), 91-100.
  • Huq, F., Abdullah, A., Chowdhury, A., Cheng, H., Tayyem, H., Beale, P. (2006). Studies on the synthesis and characterization, binding with DNA and activity of cis-Bis{imidazo(1,2-alpha)-pyridine}dichloroplatinum(II). Asian Journal of Chemistry, 18(3), 1637-1648.
  • Huq, F., Abdullah, A., Beale, P., Yu, J., Zhang, M. (2006). Studies on the synthesis, characterization and binding with DNA of cis-bis (2,3-diaminopyridine) diiodoplatinum (II): A compound with high cell uptake and drug-DNA binding but very little activity. International Journal of Pure and Applied Chemistry, 1(2), 205-211.
  • Abdullah, A., Huq, F., Chowdhury, A., Tayyem, H., Beale, P., Fisher, K. (2006). Studies on the synthesis, characterization, binding with DNA and activities of two cis-planaramineplatinum(II) complexes of the form:cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine. BMC Chemical Biology, 6, 3-1-3-9. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Beale, P., Fisher, K. (2006). Syntheses and Characterisation of Four Trinuclear Complexes of The Form: [{Trans-Ptcl(NH3)2}2m-{Trans-Pd(NH3)2(H2N(CH2)Nnh2)2]Cl4 Where N = 4 to 7. International Journal of Pure and Applied Chemistry, 1(4), 493-507.
  • Huq, F., Tayyem, H., Abdullah, A., Beale, P., Fisher, K. (2006). Synthesis and Characterization and Binding of Amine-Palladium(II) Complexes and their Interaction with DNA. Asian Journal of Chemistry, 18(1), 65-78.
  • Cheng, H., Huq, F., Beale, P., Fisher, K. (2006). Synthesis, characterisation, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}2µ-{trans-Pd(NH3)(2-hydroxypyridine)-(H2N(CH2)6NH2)2]Cl4. European Journal of Medicinal Chemistry, 41(7), 896-903. [More Information]
  • Hall, M., Alderden, R., Zhang, M., Beale, P., Cai, Z., Lai, B., Stampfl, A., Hambley, T. (2006). The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours. Journal of Structural Biology, 155(1), 38-44. [More Information]
  • Stockler, M., Heritier, S., Nowak, A., Goldstein, D., Turner, J., Jefford, M., Glasgow, A., Abdi, E., Beale, P., Carter, C. (2006). The time taken to complete quality of life questionnaires in an advanced cancer trial. Journal of Clinical Oncology, 24(18S), 491s-491s.
  • Ackland, S., Clarke, S., Beale, P., Peters, G. (2006). Thymidylate synthase inhibitors. Update on Cancer Therapeutics, 1(4), 403-427.
  • Bonnitcha, P., Hall, M., Underwood, C., Foran, G., Zhang, M., Beale, P., Hambley, T. (2006). XANES investigation of the Co oxidation state in solution and in cancer cells treated with Co(III) complexes. Journal of Inorganic Biochemistry, 100(5-6), 963-971. [More Information]
  • Clarke, S., Boyer, M., Millward, M., Underhill, C., Moylan, E., Yip, D., White, S., Childs, A., Beale, P., Latz, J., et al (2005). A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer. Lung Cancer, 49(3), 401-412. [More Information]
  • Mitchell, P., Goldstein, D., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Clarke, S. (2005). Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC). Journal of Clinical Oncology, 23(No 16S (June 1 Supplement)), 3581-3581.
  • Goldstein, D., Mitchell, P., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Clarke, S. (2005). Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients. British Journal of Cancer, 92(5), 832-837. [More Information]
  • Read, J., Beale, P., Horvath, L., Volker, D., Childs, A., Smith, N., Clarke, S. (2005). Impact of fish-oil supplement on nutritional parameters, inflammation and chemotherapy induced toxicity in colorectal cancer (CRC) patients receiving FOLFIRI - A pilot study. Journal of Clinical Oncology, 23(16S (supplement)), Abstract 8243 S789-S789.
  • Read, J., Crockett, N., Volker, D., MacLennan, P., Choy, S., Beale, P., Clarke, S. (2005). Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA). Nutrition and Cancer: an international journal, 53(1), 51-56. [More Information]
  • Chowdhury, M., Huq, F., Abdullah, A., Beale, P., Fisher, K. (2005). Synthesis, characterization and binding with DNA of four planaramineplatinum(II) complexes of the forms: trans-PtL2Cl2 and [PtL3Cl]Cl, where L = 3-hydroxypyridine, 4-hydroxypyridine and imidazo(1,2-alpha)pyridine. Journal of Inorganic Biochemistry, 99(5), 1098-1112. [More Information]
  • Cheng, H., Huq, F., Beale, P., Fisher, K. (2005). Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}(2)mu-{trans-Pt(NH3)(2-hydroxypyridine)-(H2N(CH2)(6)NH2)(2)]Cl-4. European Journal of Medicinal Chemistry, 40(8), 772-781. [More Information]
  • Daghriri, H., Huq, F., Beale, P. (2004). 'Studies On Activities, Cell Uptake And Dna Binding Of Four Multinuclear Complexes Of The Form: [{Trans-Ptcl(Nh3)2}2U-{Trans-Pd(Nh3)2-(H2N(Ch2)Nnh2)2}]Cl4 Where N = 4-7'. Journal of Inorganic Biochemistry, 98(11), 1722-1733. [More Information]
  • Cox, K., O'Connell, R., Stockler, M., Boyer, M., Beale, P., Simes, R. (2004). A randomized crossover trial of giving high-dose cisplatin with or without an overnight stay in hospital: Patients' preferences, quality of life, safety and resource use. Journal of Clinical Oncology, 22(14S), 547S-547S.
  • Vardy, J., Engelhardt, K., Cox, K., Jacquet, J., McDade, A., Boyer, M., Beale, P., Clarke, S., Stockler, M., Loneragan, R., Waugh, R., Clarke, S. (2004). Long-Term Outcome Of Radiological-Guided Insertion Of Implanted Central Venous Access Port Devices (Cvapd) For The Delivery Of Chemotherapy In Cancer Patients: Institutional Experience And Review Of The Literature. British Journal of Cancer, 91(6), 1045-1049.
  • Loneragan, R., Archer, K., Perry, A., Beale, P., Van Der Wall, H. (2004). Scintigraphy in osteitis condensans ilii. Clinical Nuclear Medicine, 29(5), 320-321.
  • Huq, F., Yu, J., Daghriri, H., Beale, P. (2004). Studies On Activities, Cell Uptake And Dna Binding Of Four Trans-Planaramineplatinum(Ii) Complexes Of The Form: Trans-Ptl(Nh3)Cl-2,Where L=2-Hydroxypyridine, Imidazole, 3-Hydroxypyridine And Imidazo(1,2-Alpha)Pyridine. Journal of Inorganic Biochemistry, 98(8), 1261-1270. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Beale, P., Fisher, K. (2004). Studies On The Synthesis And Characterization Of Four Trans-Planaramineplatinum(Ii) Complexes Of The Form Trans-Ptl(Nh3)Cl2 Where L = 2-Hydroxypyridine, 3-Hydroxypyridine, Imidazole, And Imidazo(1,2-Alpha)Pyridine. European Journal of Medicinal Chemistry, 39(8), 691-697. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Tayyem, H., Beale, P., Zhang, M. (2004). Synthesis, Characterisation, Activities, Cell Uptake And Dna Binding Of [{Trans-Ptcl(Nh3)2} {U-(H2N(Ch2)6Nh2)} {Trans-Pdcl(Nh3)2](No3)Cl. European Journal of Medicinal Chemistry, 39(11), 947-958. [More Information]
  • Hall, M., Amjadi, S., Zhang, M., Beale, P., Hambley, T. (2004). The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines. Journal of Inorganic Biochemistry, 98, 1614-1624. [More Information]
  • Joshua, A., Carter, J., Beale, P. (2004). The Use Of Taxanes In Choriocarcinoma; A Case Report And Review Of The Literature. Gynecologic Oncology, 94(2), 581-583.
  • Beale, P., Judson, I., O'Donnell, A., Trigo, J., Rees, C., Raynaud, F., Turner, A., Simmons, L., Etterley, L. (2003). A phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473). British Journal of Cancer, 88(7), 1128-1134.
  • Plummer, R., Rees, C., Hughes, A., Beale, P., Highley, M., Trigo, J., Gokul, S., Judson, I., Calvert, H., Jackman, A., et al (2003). A phase I trial of ZD9331, a water-soluble, nonployglutamatable, thymidylate synthase inhibitor. Clinical Cancer Research, 9(4), 1313-1322.
  • O'Donnell, A., Punt, C., Judson, I., Van Maanen, L., Suttle, A., Ertel, P., Beale, P. (2003). A study to evaluate the pharacokinetics of oral 5-flurouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005). Cancer Chemotherapy and Pharmacology, 51(1), 58-66. [More Information]
  • Hall, M., Hambley, T., Beale, P., Zhang, M., Dillon, C., Foran, G., Stampfl, A., Lai, B. (2003). Does platinum(IV) survive in tumour cells? Journal of Inorganic Biochemistry, 96(1), 141.
  • Alderden, R., Hall, M., Amjadi, S., Hambley, T., Beale, P., Zhang, M., Lai, M., Stampfl, A. (2003). Increasing the cellular accumulation of platinum(IV) complexes. Journal of Inorganic Biochemistry, 96(1), 89.
  • Inthasorn, P., Beale, P., Dalrymple, C., Carter, J. (2003). Malignant mixed mullerian tumour of the ovary: Prognostic factor and response of adjuvant platinum-based chemotherapy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 43(1), 61-64.
  • Rees, C., Beale, P., Trigo, J., Mitchell, F., Jackman, A., Smith, R., Douglass, E., Judson, I. (2003). Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continous infusion to patients with refractory solid malignancies. Clinical Cancer Research, 9(6), 2049-2055.
  • Hall, M., Dillon, C., Zhang, M., Beale, P., Cai, Z., Lai, B., Stampfl, A., Hambley, T. (2003). The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. Journal of Biological Inorganic Chemistry, 8(7), 726-732. [More Information]
  • Hall, M., Foran, G., Zhang, M., Beale, P., Hambley, T. (2003). XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents. Journal of the American Chemical Society, 125(25), 7524-7525.
  • Gore, M., Atkinson, R., Thomas, H., Cure, H., Rischin, D., Beale, P., Bougnoux, P., Dirix, L., Smit, W. (2002). A phase II trial of ZD0473 in platinum-pretreated ovarian cancer. European Journal of Cancer, 38(18), 2416-2420.
  • Inthasorn, P., Carter, J., Valmadre, S., Beale, P., Russell, P., Dalrymple, C. (2002). Analysis of clinicopathologic factors in malignant mixed Mullerian tumors of the uterine corpus. International Journal Of Gynecological Cancer, 12(4), 348-353.
  • Rogers, P., Beale, P., Al-Moundhri, M., Boxall, F., Patterson, L., Valenti, M., Raynaud, F., Hobbs, S., Johnston, S., Kelland, L. (2002). Overexpression of BCLxl in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo. International Journal of Cancer, 97(6), 858-863.
  • Gore, M., Atkinson, R., Thomas, H., Cure, H., Rischin, D., Beale, P., Bougnoux, P., Dirix, L., Smit, W. (2002). Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval. European Journal of Cancer, 38(supplement 8), s7-s12.
  • Clarke, S., Beale, P., Rivory, L. (2000). Clinical and preclinical pharmacokinetics of raltitrexed. Clinical Pharmacokinetics, 39, 429-443.
  • Rivory, L., Charles (nee Slaviero), K., Seale, J., Hoskins, J., Boyer, M., Beale, P., Millward, M., Bishop, J., Clarke, S. (2000). Optimizing the erythromycin breath test for use in cancer patients. Clinical Cancer Research, 6, 3480-3485.

Conferences

  • Beale, P., Daghriri, H., Huq, F. (2002). Studies on anticancer active heteronuclear metal complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Abdullah, A., Beale, P., Huq, F. (2002). Studies on planaramineplatinum (II) complexes with cis-geometry. Third Research Conference 2002 From Cell to Society, : British Medical Journal Publishing Group.
  • Beale, P., Cheng, H., Huq, F. (2002). Studies on polynuclear complexes with different coordination geometries. From Cell to Society 3, : British Medical Journal Publishing Group.
  • Beale, P., Huq, F., Mohammad, F. (2002). Studies on polynuclear palladium complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Yu, J., Beale, P., Huq, F. (2002). Studies on transplanaramineplatinum (II) complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Huq, F., Beale, P., Yu, J. (2001). Studies on new tumour-active metal complexes. 10th International Conference on Bioinorganic Chemistry, : Ads & Adea.

2014

  • Huq, F., Yu, J., Beale, P., Chan, C., Arzuman, L., Nessa, M., Mazumder, M. (2014). Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer. Anticancer Research, 34(1), 541-545.
  • Wu, J., Ludlow, J., De Vries, B., Black, K., Beale, P. (2014). Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success. Australian and New Zealand Journal of Obstetrics and Gynaecology, 54(5), 469-474. [More Information]
  • Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres. Journal of Biomedical Science, 21(1), 1-12. [More Information]
  • Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and Antitumour Activity of a New Trinuclear Platinum Compound [{cis-PtCI(NH3)2u {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] CI4 in Human Ovarian Cancer Cells. Anticancer Research, 34(4), 1923-1929.

2013

  • Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2013). Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumor models. Journal of Ovarian Research, 6(Nov 2013), 1-11. [More Information]
  • Vardy, J., Dhillon, H., Clarke, S., Olesen, I., Leslie, F., Warby, A., Beith, J., Sullivan, A., Hamilton, A., Beale, P., Rittau, A., McLachlan, A. (2013). Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus, 2(1), 1-5. [More Information]
  • Stark, D., Nankivell, M., Pujade-Lauraine, E., Kristensen, G., Elit, L., Stockler, M., Hilpert, F., Cervantes, A., Brown, J., Lanceley, A., et al (2013). Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. Lancet Oncology, 14(3), 236-243. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2013). Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models. Medicinal Chemistry, 9(4), 539-544. [More Information]
  • Lim, S., Wilson, S., Hunter, A., Jane, H., Beale, P. (2013). Takotsubo Cardiomyopathy and 5-Fluorouracil: Getting to the Heart of the Matter. Case Reports in Oncological Medicine, 2013, 206765. [More Information]
  • Kiely, B., Martin, A., Tattersall, M., Nowak, A., Goldstein, D., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Stockler, M., et al (2013). The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates. Journal of Clinical Oncology, 31(28), 3565-3571. [More Information]
  • Kiely, B., McCaughan, G., Christodoulou, S., Beale, P., Grimison, P., Trotman, J., Tattersall, M., Stockler, M. (2013). Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer, 21(2), 369-376. [More Information]

2012

  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells. Anticancer Research, 32(1), 53-59. [More Information]
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Lee, M., Rosenthal, D., Larkey, L., Vardy, J. (2012). Effect of Medical Qigong on Cognitive function, Quality of Life and a Biomarker of Inflammation in Cancer Patients: A Randomized Controlled Trial. Supportive Care in Cancer, 20(6), 1235-1242. [More Information]
  • Mazumder, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Epigallocatechin Gallate Acts Synergistically in Combination with Cisplatin and Designed trans-palladiums in Ovarian Cancer Cells. Anticancer Research, 32(11), 4851-4860. [More Information]
  • Dimoska, A., Butow, P., Lynch, J., Hovey, E., Agar, M., Beale, P., Tattersall, M. (2012). Implementing patient question-prompt lists into routine cancer care. Patient Education and Counseling, 86(2), 252-258. [More Information]
  • Chua, W., Horvath, L., Beale, P., Clarke, S. (2012). Reporting clinical trial information: colorectal cancer trials at Sydney Cancer Centre. Internal Medicine Journal, 42(4), 416-421. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Studies on combination of platinum drugs Cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models. Anticancer Research, 32(11), 4843-4850. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Huq, F. (2012). Studies on the activity of two trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models. Anticancer Research, 32(12), 5331-5336. [More Information]
  • Hamad, S., Beale, P., Yu, J., Fisher, K., Huq, F. (2012). Synthesis and Activity of [{Cis-PtC1(NH3)2}2m{Trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]C14 in the human ovarian tumour models. Medicinal Chemistry, 8(3), 384-391. [More Information]
  • Mazumder, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Synthesis and Cytotoxicity of Three trans-Palladium Complexes Containing Planaramine Ligands in Human Ovarian Tumor Models. ChemMedChem: chemistry enabling drug discovery, 7(10), 1840-1846. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2012). Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models. Anticancer Research, 32(1), 135-140. [More Information]
  • Kho, P., Chapuis, P., Beale, P., Bokey, E., Dent, O., Clarke, S. (2012). Use of adjuvant chemotherapy in stage C (III) rectal cancer: Comparison of data from matched patients in a teaching hospital's clinico-pathological database. Asia-Pacific Journal of Clinical Oncology, 8(4), 346-355. [More Information]

2011

  • Anderson, C., Carter, J., Nattress, K., Beale, P., Philp, S., Harrison, J., Juraskova, I. (2011). "The Booklet Helped Me Not to Panic" A Pilot of a Decision Aid for Asymptomatic Women With Ovarian Cancer and With Rising CA-125 Levels. International Journal of Gynecological Cancer, 21(4), 737-743. [More Information]
  • Perren, T., Swart, A., Pfisterer, J., Ledermann, J., Pujade-Lauraine, E., Kristensen, G., Carey, M., Beale, P., Cervantes, A., Kurzeder, C., et al (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26), 2484-2496. [More Information]
  • Friedlander, M., Trimble, E., Tinker, A., Alberts, D., Avall-Lundqvist, E., Brady, M., Harter, P., Pignata, S., Pujade- Lauraine, E., Sehouli, J., Beale, P., et al (2011). Clinical Trials in Recurrent Ovarian Cancer. International Journal Of Gynecological Cancer, 21(4), 771-775. [More Information]
  • Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2011). Modulation of Cisplatin Cytotoxicity due to its Combination with Bortezomib and the Nature of its Administration. Anticancer Research, 31(9), 2757-2762. [More Information]
  • Cox, K., Goel, S., O'Connell, R., Boyer, M., Beale, P., Simes, R., Stockler, M. (2011). Randomized cross-over trial comparing inpatient and outpatient administration of high-dose cisplatin. Internal Medicine Journal, 41(2), 172-178. [More Information]
  • Al-Shuneigat, J., Qing, Y., Beale, P., Fisher, K., Huq, F. (2011). Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3). Medicinal Chemistry, 7(1), 1-8. [More Information]
  • Leighl, N., Shepherd, H., Butow, P., Clarke, S., McJannett, M., Beale, P., Wilcken, N., Moore, M., Chen, E., Goldstein, D., Horvath, L., Tattersall, M., et al (2011). Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering Chemotherapy. Journal of Clinical Oncology, 29(15), 2077-2084. [More Information]
  • Alshehri, A., Beale, P., Yu, J., Huq, F. (2011). Synergism from Combination of Cisplatin and Multicentred Platinums Coded as DH6Cl and TH1 in the Human Ovarian Tumour Models. Medicinal Chemistry, 7(6), 593-598. [More Information]
  • Yunos, N., Beale, P., Yu, J., Huq, F. (2011). Synergism from Sequenced Combinations of Curcumin and Epigallocatechin-3-gallate with Cisplatin in the Killing of Human Ovarian Cancer Cells. Anticancer Research, 31(4), 1131-1140. [More Information]
  • Yunos, N., Beale, P., Yu, J., Huq, F. (2011). Synergism from the Combination of Oxaliplatin with Selected Phytochemicals in Human Ovarian Cancer Cell Lines. Anticancer Research, 31(12), 4283-4289. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2011). Synergism from Vombinations of Cisplatin and Oxaliplatin with Quercetin and Thymoquinone in Human Ovarian Tumour Models. Anticancer Research, 31(11), 3789-3797. [More Information]

2010

  • Blinman, P., Duric, V., Nowak, A., Beale, P., Clarke, S., Briscoe, K., Boyce, A., Goldstein, D., Hudson, M., Stockler, M. (2010). Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile? European Journal of Cancer, 46(10), 1800-1807. [More Information]
  • Lam, F., Jankova, L., Dent, O., Molloy, M., Kwun, S., Clarke, C., Chapuis, P., Robertson, G., Beale, P., Clarke, S., Bokey, E., Chan, C. (2010). Identification of distinctive protein expression patterns in colorectal adenoma. Proteomics - Clinical Applications, 4(1), 60-70. [More Information]
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Kothe, E., Lam, L., Rosenthal, D. (2010). Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Annals of Oncology, 21(3), 608-614. [More Information]
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Tattersall, M., Boyer, M., Beale, P., Vardy, J., Pavlakis, N., Larke, L. (2010). Patient-Doctor Communication: Use of Complementary and Alternative Medicine by Adult Patients with Cancer. Journal of the Society for Integrative Oncology, 8(2), 56-64. [More Information]
  • Yunos, N., Beale, P., Yu, J., Strain, D., Huq, F. (2010). Studies on combinations of platinum with Paclitaxel and colchicine in ovarian cancer cell lines. Anticancer Research, 30(10), 4025-4037. [More Information]
  • Al-Shuneigat, J., Yu, J., Beale, P., Fisher, K., Huq, F. (2010). Studies on Two New mixed Ligand Platinum Compounds with a Trans-Geometry. Medicinal Chemistry, 6(5), 321-328. [More Information]
  • Alshehri, A., Beale, P., Yu, J., Huq, F. (2010). Synergism from combination of Cisplatin and a trans-platinum compound in ovarian cancer cell lines. Anticancer Research, 30(11), 4547-4553. [More Information]
  • Oh, B., Butow, P., Mullan, B., Beale, P., Pavlakis, N., Rosenthal, D., Clarke, S. (2010). The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia-Pacific Journal of Clinical Oncology, 6(4), 342-349. [More Information]

2009

  • Chapuis, P., Bokey, E., Clarke, S., Beale, P., Dent, O. (2009). Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting. ANZ Journal of Surgery, 79(10), 685-692. [More Information]
  • Vardy, J., Dadasovich, R., Beale, P., Boyer, M., Clarke, S. (2009). Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC Cancer, 9(Article number 130), 130-1-130-6. [More Information]
  • Kao, S., Mahon, K., Rutland, J., Pawsey, C., McCaughan, B., Beale, P. (2009). Pleural well-differentiated papillary mesothelioma: a case report. Journal of Thoracic Oncology, 4(7), 920-922. [More Information]
  • Harrison, J., Juraskova, I., Anderson, C., Nattress, K., Beale, P., Lopez, A., Carter, J. (2009). Rising cancer antigen 125 level and the type and timing of treatment for recurrent ovarian cancer: a clinical dilemma, but what would women do? International Journal of Gynecological Cancer, 19(6), 1037-1046. [More Information]
  • Huq, F., Beale, P., Yu, J. (2009). Studies on New Platinum Compounds. In Andrea Bonetti, Roberto Leone,Franco M Muggia, Stephen B Howell (Eds.), Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, (pp. 11-17). US: Humana Press.
  • Farhad, M., Yu, J., Beale, P., Fisher, K., Huq, F. (2009). Studies on the synthesis and activity of three tripalladium complexes containing planaramine ligands. ChemMedChem: chemistry enabling drug discovery, 4(11), 1841-1849. [More Information]
  • Huq, F., Tayyem, H., Yu, J., Beale, P., Fisher, K. (2009). Synthesis, activity and binding with DNA of [{trans-PtCl(NH3)2}2mu-{trans-Pd(4-hydroxypyridine)2(H2N(CH2)6NH2)2]Cl4 (TH8). Medicinal Chemistry, 5(4), 372-381. [More Information]
  • Diakos, C., Zhang, M., Beale, P., Fenton, R., Hambley, T. (2009). Synthesis, characterisation and in vitro cytotoxicity studies of a series of chiral platinum(II) complexes based on the 2-aminomethylpyrrolidine ligand: X-ray crystal structure of [PtC12(R-dimepyrr)] (R-dimepyrr = N-dimethyl-2(R)-aminomethylpyrrolidine). European Journal of Medicinal Chemistry, 44(7), 2807-2814. [More Information]
  • Chua, W., Moore, M., Beale, P., Clarke, S. (2009). Third-line Treatment Options for Metastatic Colorectal Cancer. Asia Pacific Journal of Oncology and Hematology, 1(1), 27-35.

2008

  • Van Cutsem, E., Verslype, C., Beale, P., Clarke, S., Bugat, R., Rakhit, A., Fettner, S., Brennscheidt, U., Feyereislova, A., Delord, J. (2008). A phase lb dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients. Annals of Oncology, 19(2), 332-339. [More Information]
  • Chua, W., Beale, P., Clarke, S., Leung, M. (2008). Retrospective review of mitomycin C use as third-line chemotherapy in metastatic colorectal cancer. Asia-Pacific Journal of Clinical Oncology, 4(3), 132-136.
  • Tayyem, H., Huq, F., Yu, J., Beale, P., Fisher, K. (2008). Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH(3))(2)}(2)mu-{trans-Pt(3-hydroxypyridine)(2)(H(2)N(CH(2))(6)NH(2))(2)}]Cl(4) in ovarian cancer cell lines. ChemMedChem: chemistry enabling drug discovery, 3(1), 145-151. [More Information]

2007

  • Stockler, M., O'Connell, R., Nowak, A., Goldstein, D., Turner, J., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Dhillon, H., Heritier, S., Carter, C., Hickie, I., Simes, R., et al (2007). Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncology, 8(7), 603-612. [More Information]
  • Yeo, W., Boyer, M., Chung, H., Ong, S., Lim, R., Zee, B., Ma, B., Lam, K., Mo, F., Ng, E., Clarke, S., Beale, P., et al (2007). Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG). Cancer Chemotherapy and Pharmacology, 59(3), 295-300. [More Information]
  • Clarke, S., Goldstein, D., Mitchell, P., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S. (2007). Modification of Leucovorin Dose Within a Simplified FOLFOX Regimen Improves Tolerability Without Compromising Efficacy. Clinical Colorectal Cancer, 6(8), 578-582. [More Information]
  • Harnett, P., Buck, M., Beale, P., Goldrick, A., Allan, S., Fitzharris, B., De Souza, P., Links, M., Kalimi, G., Davies, T., et al (2007). Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study. International Journal Of Gynecological Cancer, 17(2), 359-366. [More Information]
  • Tinker, A., Gebski, V., Fitzharris, B., Buck, M., Stuart-Harris, R., Beale, P., Goldrick, A., Rischin, D. (2007). Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel-ANZGOG 02-01. Gynecologic Oncology, 104(3), 647-653. [More Information]
  • Leighl, N., Shepherd, H., Butow, P., Clarke, S., McJannett, M., Beale, P., Wilcken, N., Moore, M., Chen, E., Tattersall, M., Goldstein, D. (2007). When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer. Journal of Clinical Oncology, 25(18S), 6509.

2006

  • Soo, R., Wang, L., Tham, L., Yong, W., Boyer, M., Lee, H., Lim, H., Millward, M., Liang, S., Beale, P., et al (2006). A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer. Annals of Oncology, 17(7), 1128-1133.
  • Sharma, R., Rivory, L., Beale, P., Ong, S., Horvath, L., Clarke, S. (2006). A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer. British Journal of Cancer, 94(7), 964-968. [More Information]
  • Tobin, P., Beale, P., Noney, L., Liddell, S., Rivory, L., Clarke, S. (2006). A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology, 57(3), 309-316. [More Information]
  • Mitchell, P., Goldstein, D., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Thomson, J., Clarke, S. (2006). Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity. Clinical Colorectal Cancer, 6(2), 146-151. [More Information]
  • Read, J., Choy, S., Beale, P., Clarke, S. (2006). An evaluation of the prevalence of malnutrition in cancer patients attending the outpatient oncology clinic. Asia-Pacific Journal of Clinical Oncology, 2(2), 80-86.
  • Huq, F., Abdullah, A., Beale, P. (2006). Antitumour activity of cis-bis{imidazo(1,2-alpha)pyridineplatinum(II). International Journal of Cancer Research, 2(4), 367-375.
  • Stockler, M., Tattersall, M., Boyer, M., Clarke, S., Beale, P., Simes, R. (2006). Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer. British Journal of Cancer, 94(2), 208-212. [More Information]
  • Read, J., Choy, S., Beale, P., Clarke, S. (2006). Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutrition and Cancer: an international journal, 55(1), 78-85. [More Information]
  • Carter, J., Pather, S., ABDEL-HADI, M., Nattress, K., Dalrymple, C., Beale, P. (2006). Not all ovarian cysts in young woman are benign: A case series and review of the management of complex adnexal masses in young women. Australian and New Zealand Journal of Obstetrics and Gynaecology, 46(4), 350-355. [More Information]
  • Read, J., Beale, P., Volker, D., Smith, N., Childs, A., Clarke, S. (2006). Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Supportive Care in Cancer, 15(3), 301-307. [More Information]
  • Charles (nee Slaviero), K., Rivory, L., Stockler, M., Beale, P., Beith, J., Boyer, M., Clarke, S. (2006). Predicting the toxicity of weekly docetaxel in advanced cancer. Clinical Pharmacokinetics, 45(6), 611-622. [More Information]
  • Michael, M., Goldstein, D., Clarke, S., Milner, A., Beale, P., Friedlander, M., Mitchell, P. (2006). Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count. Clinical Colorectal Cancer, 6(4), 297-304.
  • Huq, F., Farhad, M., Abdullah, A., Beale, P., Zhang, M. (2006). Studies on Oligonuclear Palladium Complexes. Asian Journal of Chemistry, 18(3), 1607-1625.
  • Huq, F., Farhad, M., Abdullah, A., Beale, P., Zhang, M. (2006). Studies on Oligonuclear Palladium Complexes. Asian Journal of Chemistry, 18(3), 1607-1625.
  • Huq, F., Tayyem, H., Beale, P., Yu, J. (2006). Studies on the activity of three palladium(II) compounds of the form: Trans-PdL(2)Cl(2) where L=2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxypyridine. Journal of Inorganic Biochemistry, 101(1), 30-35. [More Information]
  • Huq, F., Abdullah, A., Chowdhury, A., Tayyem, H., Beale, P., Fisher, K. (2006). Studies on the synthesis and characterization, and binding with DNA of two Cis-Planaramineplatinum(II) complexes of the forms: Cis-PtL2Cl2 and Cis-PtL(NH3)Cl2 and where L=3-hydroxypyridine and imidazo(1,2-αlpha) Pyridine. International Journal of Pure and Applied Chemistry, 1(1), 91-100.
  • Huq, F., Abdullah, A., Chowdhury, A., Cheng, H., Tayyem, H., Beale, P. (2006). Studies on the synthesis and characterization, binding with DNA and activity of cis-Bis{imidazo(1,2-alpha)-pyridine}dichloroplatinum(II). Asian Journal of Chemistry, 18(3), 1637-1648.
  • Huq, F., Abdullah, A., Beale, P., Yu, J., Zhang, M. (2006). Studies on the synthesis, characterization and binding with DNA of cis-bis (2,3-diaminopyridine) diiodoplatinum (II): A compound with high cell uptake and drug-DNA binding but very little activity. International Journal of Pure and Applied Chemistry, 1(2), 205-211.
  • Abdullah, A., Huq, F., Chowdhury, A., Tayyem, H., Beale, P., Fisher, K. (2006). Studies on the synthesis, characterization, binding with DNA and activities of two cis-planaramineplatinum(II) complexes of the form:cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine. BMC Chemical Biology, 6, 3-1-3-9. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Beale, P., Fisher, K. (2006). Syntheses and Characterisation of Four Trinuclear Complexes of The Form: [{Trans-Ptcl(NH3)2}2m-{Trans-Pd(NH3)2(H2N(CH2)Nnh2)2]Cl4 Where N = 4 to 7. International Journal of Pure and Applied Chemistry, 1(4), 493-507.
  • Huq, F., Tayyem, H., Abdullah, A., Beale, P., Fisher, K. (2006). Synthesis and Characterization and Binding of Amine-Palladium(II) Complexes and their Interaction with DNA. Asian Journal of Chemistry, 18(1), 65-78.
  • Cheng, H., Huq, F., Beale, P., Fisher, K. (2006). Synthesis, characterisation, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}2µ-{trans-Pd(NH3)(2-hydroxypyridine)-(H2N(CH2)6NH2)2]Cl4. European Journal of Medicinal Chemistry, 41(7), 896-903. [More Information]
  • Hall, M., Alderden, R., Zhang, M., Beale, P., Cai, Z., Lai, B., Stampfl, A., Hambley, T. (2006). The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours. Journal of Structural Biology, 155(1), 38-44. [More Information]
  • Stockler, M., Heritier, S., Nowak, A., Goldstein, D., Turner, J., Jefford, M., Glasgow, A., Abdi, E., Beale, P., Carter, C. (2006). The time taken to complete quality of life questionnaires in an advanced cancer trial. Journal of Clinical Oncology, 24(18S), 491s-491s.
  • Ackland, S., Clarke, S., Beale, P., Peters, G. (2006). Thymidylate synthase inhibitors. Update on Cancer Therapeutics, 1(4), 403-427.
  • Bonnitcha, P., Hall, M., Underwood, C., Foran, G., Zhang, M., Beale, P., Hambley, T. (2006). XANES investigation of the Co oxidation state in solution and in cancer cells treated with Co(III) complexes. Journal of Inorganic Biochemistry, 100(5-6), 963-971. [More Information]

2005

  • Clarke, S., Boyer, M., Millward, M., Underhill, C., Moylan, E., Yip, D., White, S., Childs, A., Beale, P., Latz, J., et al (2005). A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer. Lung Cancer, 49(3), 401-412. [More Information]
  • Mitchell, P., Goldstein, D., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Clarke, S. (2005). Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC). Journal of Clinical Oncology, 23(No 16S (June 1 Supplement)), 3581-3581.
  • Goldstein, D., Mitchell, P., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Clarke, S. (2005). Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients. British Journal of Cancer, 92(5), 832-837. [More Information]
  • Read, J., Beale, P., Horvath, L., Volker, D., Childs, A., Smith, N., Clarke, S. (2005). Impact of fish-oil supplement on nutritional parameters, inflammation and chemotherapy induced toxicity in colorectal cancer (CRC) patients receiving FOLFIRI - A pilot study. Journal of Clinical Oncology, 23(16S (supplement)), Abstract 8243 S789-S789.
  • Read, J., Crockett, N., Volker, D., MacLennan, P., Choy, S., Beale, P., Clarke, S. (2005). Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA). Nutrition and Cancer: an international journal, 53(1), 51-56. [More Information]
  • Chowdhury, M., Huq, F., Abdullah, A., Beale, P., Fisher, K. (2005). Synthesis, characterization and binding with DNA of four planaramineplatinum(II) complexes of the forms: trans-PtL2Cl2 and [PtL3Cl]Cl, where L = 3-hydroxypyridine, 4-hydroxypyridine and imidazo(1,2-alpha)pyridine. Journal of Inorganic Biochemistry, 99(5), 1098-1112. [More Information]
  • Cheng, H., Huq, F., Beale, P., Fisher, K. (2005). Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}(2)mu-{trans-Pt(NH3)(2-hydroxypyridine)-(H2N(CH2)(6)NH2)(2)]Cl-4. European Journal of Medicinal Chemistry, 40(8), 772-781. [More Information]

2004

  • Daghriri, H., Huq, F., Beale, P. (2004). 'Studies On Activities, Cell Uptake And Dna Binding Of Four Multinuclear Complexes Of The Form: [{Trans-Ptcl(Nh3)2}2U-{Trans-Pd(Nh3)2-(H2N(Ch2)Nnh2)2}]Cl4 Where N = 4-7'. Journal of Inorganic Biochemistry, 98(11), 1722-1733. [More Information]
  • Cox, K., O'Connell, R., Stockler, M., Boyer, M., Beale, P., Simes, R. (2004). A randomized crossover trial of giving high-dose cisplatin with or without an overnight stay in hospital: Patients' preferences, quality of life, safety and resource use. Journal of Clinical Oncology, 22(14S), 547S-547S.
  • Vardy, J., Engelhardt, K., Cox, K., Jacquet, J., McDade, A., Boyer, M., Beale, P., Clarke, S., Stockler, M., Loneragan, R., Waugh, R., Clarke, S. (2004). Long-Term Outcome Of Radiological-Guided Insertion Of Implanted Central Venous Access Port Devices (Cvapd) For The Delivery Of Chemotherapy In Cancer Patients: Institutional Experience And Review Of The Literature. British Journal of Cancer, 91(6), 1045-1049.
  • Loneragan, R., Archer, K., Perry, A., Beale, P., Van Der Wall, H. (2004). Scintigraphy in osteitis condensans ilii. Clinical Nuclear Medicine, 29(5), 320-321.
  • Huq, F., Yu, J., Daghriri, H., Beale, P. (2004). Studies On Activities, Cell Uptake And Dna Binding Of Four Trans-Planaramineplatinum(Ii) Complexes Of The Form: Trans-Ptl(Nh3)Cl-2,Where L=2-Hydroxypyridine, Imidazole, 3-Hydroxypyridine And Imidazo(1,2-Alpha)Pyridine. Journal of Inorganic Biochemistry, 98(8), 1261-1270. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Beale, P., Fisher, K. (2004). Studies On The Synthesis And Characterization Of Four Trans-Planaramineplatinum(Ii) Complexes Of The Form Trans-Ptl(Nh3)Cl2 Where L = 2-Hydroxypyridine, 3-Hydroxypyridine, Imidazole, And Imidazo(1,2-Alpha)Pyridine. European Journal of Medicinal Chemistry, 39(8), 691-697. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Tayyem, H., Beale, P., Zhang, M. (2004). Synthesis, Characterisation, Activities, Cell Uptake And Dna Binding Of [{Trans-Ptcl(Nh3)2} {U-(H2N(Ch2)6Nh2)} {Trans-Pdcl(Nh3)2](No3)Cl. European Journal of Medicinal Chemistry, 39(11), 947-958. [More Information]
  • Hall, M., Amjadi, S., Zhang, M., Beale, P., Hambley, T. (2004). The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines. Journal of Inorganic Biochemistry, 98, 1614-1624. [More Information]
  • Joshua, A., Carter, J., Beale, P. (2004). The Use Of Taxanes In Choriocarcinoma; A Case Report And Review Of The Literature. Gynecologic Oncology, 94(2), 581-583.

2003

  • Beale, P., Judson, I., O'Donnell, A., Trigo, J., Rees, C., Raynaud, F., Turner, A., Simmons, L., Etterley, L. (2003). A phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473). British Journal of Cancer, 88(7), 1128-1134.
  • Plummer, R., Rees, C., Hughes, A., Beale, P., Highley, M., Trigo, J., Gokul, S., Judson, I., Calvert, H., Jackman, A., et al (2003). A phase I trial of ZD9331, a water-soluble, nonployglutamatable, thymidylate synthase inhibitor. Clinical Cancer Research, 9(4), 1313-1322.
  • O'Donnell, A., Punt, C., Judson, I., Van Maanen, L., Suttle, A., Ertel, P., Beale, P. (2003). A study to evaluate the pharacokinetics of oral 5-flurouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005). Cancer Chemotherapy and Pharmacology, 51(1), 58-66. [More Information]
  • Hall, M., Hambley, T., Beale, P., Zhang, M., Dillon, C., Foran, G., Stampfl, A., Lai, B. (2003). Does platinum(IV) survive in tumour cells? Journal of Inorganic Biochemistry, 96(1), 141.
  • Alderden, R., Hall, M., Amjadi, S., Hambley, T., Beale, P., Zhang, M., Lai, M., Stampfl, A. (2003). Increasing the cellular accumulation of platinum(IV) complexes. Journal of Inorganic Biochemistry, 96(1), 89.
  • Inthasorn, P., Beale, P., Dalrymple, C., Carter, J. (2003). Malignant mixed mullerian tumour of the ovary: Prognostic factor and response of adjuvant platinum-based chemotherapy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 43(1), 61-64.
  • Rees, C., Beale, P., Trigo, J., Mitchell, F., Jackman, A., Smith, R., Douglass, E., Judson, I. (2003). Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continous infusion to patients with refractory solid malignancies. Clinical Cancer Research, 9(6), 2049-2055.
  • Hall, M., Dillon, C., Zhang, M., Beale, P., Cai, Z., Lai, B., Stampfl, A., Hambley, T. (2003). The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. Journal of Biological Inorganic Chemistry, 8(7), 726-732. [More Information]
  • Hall, M., Foran, G., Zhang, M., Beale, P., Hambley, T. (2003). XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents. Journal of the American Chemical Society, 125(25), 7524-7525.

2002

  • Gore, M., Atkinson, R., Thomas, H., Cure, H., Rischin, D., Beale, P., Bougnoux, P., Dirix, L., Smit, W. (2002). A phase II trial of ZD0473 in platinum-pretreated ovarian cancer. European Journal of Cancer, 38(18), 2416-2420.
  • Inthasorn, P., Carter, J., Valmadre, S., Beale, P., Russell, P., Dalrymple, C. (2002). Analysis of clinicopathologic factors in malignant mixed Mullerian tumors of the uterine corpus. International Journal Of Gynecological Cancer, 12(4), 348-353.
  • Rogers, P., Beale, P., Al-Moundhri, M., Boxall, F., Patterson, L., Valenti, M., Raynaud, F., Hobbs, S., Johnston, S., Kelland, L. (2002). Overexpression of BCLxl in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo. International Journal of Cancer, 97(6), 858-863.
  • Gore, M., Atkinson, R., Thomas, H., Cure, H., Rischin, D., Beale, P., Bougnoux, P., Dirix, L., Smit, W. (2002). Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval. European Journal of Cancer, 38(supplement 8), s7-s12.
  • Beale, P., Daghriri, H., Huq, F. (2002). Studies on anticancer active heteronuclear metal complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Abdullah, A., Beale, P., Huq, F. (2002). Studies on planaramineplatinum (II) complexes with cis-geometry. Third Research Conference 2002 From Cell to Society, : British Medical Journal Publishing Group.
  • Beale, P., Cheng, H., Huq, F. (2002). Studies on polynuclear complexes with different coordination geometries. From Cell to Society 3, : British Medical Journal Publishing Group.
  • Beale, P., Huq, F., Mohammad, F. (2002). Studies on polynuclear palladium complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Yu, J., Beale, P., Huq, F. (2002). Studies on transplanaramineplatinum (II) complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.

2001

  • Huq, F., Beale, P., Yu, J. (2001). Studies on new tumour-active metal complexes. 10th International Conference on Bioinorganic Chemistry, : Ads & Adea.

2000

  • Clarke, S., Beale, P., Rivory, L. (2000). Clinical and preclinical pharmacokinetics of raltitrexed. Clinical Pharmacokinetics, 39, 429-443.
  • Rivory, L., Charles (nee Slaviero), K., Seale, J., Hoskins, J., Boyer, M., Beale, P., Millward, M., Bishop, J., Clarke, S. (2000). Optimizing the erythromycin breath test for use in cancer patients. Clinical Cancer Research, 6, 3480-3485.

To update your profile click here. For support on your academic profile contact .